Industry
Industry
Sponsored by
A new scientific publication on the beneficial effect of probiotics on mood and sleep in healthy adults facing daily stress situation during COVID-19 pandemic.
Lactobacillus plantarum P 17630 has obtained marketing authorization from the health authorities of the first group of EU states for the topical vaginal drug in soft and hard capsules.
Christopher Reyes, CEO, Co-Founder and Director at Bloom Science, spoke about the new class of microbe-based therapeutics for neurological disorders the company is working on.
Industry
Sponsored by
Final EU authorization of LNT, 3-FL and 3’-SL for safe use in infant formula at the highest dosage levels
Herve Affagard, Chief Executive Officer at MaaT Pharma, gives us an update on the clinical trials (Maat013 and Maat033) and describes the vision of the company for the future of the…
The International Probiotics Association’s expansion is part of the organization’s strategy to help the ’biotics’ industry grow in response to market demands.
MicrobiomePost discussed with Claire Derlot, Head of Programs at Biose Industrie, the GMP challenges when you have to go from bacteria to a drug.
Rebyota is the first and only FDA-approved Microbiome-Based Treatment for the prevention of recurrence of C. diff infection in adults.
Chicago-based company said it invested more than $30 million to help meet rising global demand
MicrobiomePost talked with Isabelle de Cremoux, CEO of Seventure Partners, about the news that will emerge in 2023.
